Cargando…
Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis
PURPOSE: Several studies have suggested that an HLA-Cw6+ allele can predict an improved outcome of treatment in psoriasis patients. The aim of the study was to assess whether the published association between HLA-Cw6 allele carriers and response to ustekinumab has the potential to impact treatment d...
Autores principales: | Anzengruber, Florian, Ghosh, Adhideb, Maul, Julia-Tatjana, Drach, Mathias, Navarini, Alexander A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919162/ https://www.ncbi.nlm.nih.gov/pubmed/29721444 http://dx.doi.org/10.2147/PTT.S161437 |
Ejemplares similares
-
Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab
por: De Keyser, Eline, et al.
Publicado: (2019) -
HLA-Cw1 and Psoriasis
por: Huang, Yi-Wei, et al.
Publicado: (2021) -
The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis
por: Burlando, Martina, et al.
Publicado: (2020) -
The role of HLA-Cw6 in psoriasis and psoriatic arthritis
por: Owczarek, Witold
Publicado: (2022) -
HLA-Cw6 Status and Treatment Responses Between Psoriasis Patients
por: Temel, Berkay, et al.
Publicado: (2021)